On December 5, 2019 Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, reported that Mr. Jed Latkin, Chief Executive Officer, will present at the 12th Annual LD Micro Main Event investor conference (Press release, Navidea Biopharmaceuticals, DEC 5, 2019, View Source [SID1234551967]). The conference will be held at the Luxe Bel Air Hotel in Los Angeles, CA on December 10-12, 2019. Mr. Latkin will present on Wednesday, December 11 at 10:20 a.m. PT (1:20 p.m. ET) in Track 4, which will be webcast.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Details of Navidea’s presentation are below. For those who wish to listen to the live webcast, please use the following link: View Source." target="_blank" title="View Source." rel="nofollow">View Source The webcast will be archived on Navidea’s investor relations website, View Source for 90 days following the live presentation.
Event:
12th Annual LD Micro Main Event
Date:
Wednesday, December 11, 2019
Time:
10:20 a.m. PT (1:20 p.m. ET)
Location:
Luxe Sunset Boulevard Hotel, Los Angeles, CA – Track 4
Webcast:
The 12th Annual LD Micro Main Event will feature 275 emerging growth companies and is expected to attract 1,500 attendees. To schedule a one-on-one meeting with Mr. Latkin, please contact Adam Holdsworth at [email protected].